Kairos Pharma Ltd
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Kairos Pharma Ltd
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. It is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.
/ 
Frequently asked questions
To buy Kairos Pharma Ltd stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Kairos Pharma Ltd by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Kairos Pharma Ltd is KAPA:xase. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Kairos Pharma Ltd has its primary listing on NYSE American. You can trade Kairos Pharma Ltd with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Kairos Pharma Ltd is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Kairos Pharma Ltd as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Kairos Pharma Ltd.